Evidence map›Paper›PMID 28838133›Full record

ArticleThe Journal of infectious diseases2017

The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.

Nina Moe, Inger Heimdal Stenseng, Sidsel Krokstad, Andreas Christensen, Lars Høsøien Skanke, Kari Ravndal Risnes, Svein Arne Nordbø, Henrik Døllner

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. The re-emergence of HMPV: a wake-up call for public health systems.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nina MoeDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.
Inger Heimdal StensengDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.
Sidsel KrokstadMedical Microbiology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Andreas ChristensenDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.
Lars Høsøien SkankeDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.
Kari Ravndal RisnesDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.
Svein Arne NordbøDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.
Henrik DøllnerDepartment of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The burden of severe human metapneumovirus (HMPV) respiratory tract infections (RTIs) in European children has not been clarified. We assessed HMPV in Norwegian children and compared hospitalization rates for HMPV and respiratory syncytial virus (RSV). Methods: We prospectively enrolled children (<16 years old) hospitalized with RTI and asymptomatic controls (2006-2015). Nasopharyngeal aspirate samples were analyzed with polymerase chain reaction (PCR) tests for HMPV, RSV, and 17 other pathogens. We genotyped HMPV-positive samples and assessed shedding time in 32 HMPV-infected children. Results: In children with RTI, HMPV was detected in 7.3% (267 of 3650) and RSV in 28.7% (1048 of 3650). Among controls, 2.1% (7 of 339) had low HMPV levels detected by PCR, but all were culture negative. HMPV primarily occurred from January to April and in regular epidemics. At least 2 HMPV subtypes occurred each season. The average annual hospitalization rates in children <5 years old with lower RTI were 1.9/1000 (HMPV) and 10.4/1000 (RSV). Among children with RTI, the median HMPV shedding time by PCR was 13 days (range, 6-28 days), but all were culture negative (noninfectious) after 13 days. Conclusions: HMPV appears in epidemics in Norwegian children, with a hospitalization rate 5 times lower than RSV. Low levels of HMPV are rarely detected in healthy children.

Indexed as

Child, HospitalizedChild, PreschoolCost of IllnessFemaleFollow-Up StudiesHumansInfantMaleMetapneumovirusNorwayPolymerase Chain ReactionProspective StudiesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract Infectionsburden of respiratory tract infectionshospitalization ratehuman metapneumovirusrespiratory syncytial virusvirus shedding time

Identifiers

PMID28838133
PMCPMC7107394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.